CDK2 and ovarian cancer: Similarly, reduction of levels of the ribosomal protein RPS6 in ovarian cancer cells caused downregulation of CDK2, CDK4, CDK6, cyclin E, and cyclin D1, thereby blocking the transition from G0/G1 to S phase and suppressing cell proliferation [32].